Unfavourable cardiovascular disease risk profiles in a cohort of Dutch and British haemophilia patients

Thrombosis and Haemostasis

Volumn 109, Issue 1, 2013, Pages 16-23

  van de Putte, Dietje E Fransen ^a   Fischer, Kathelijn ^a,b   Makris, Michael ^c   Tait, R Campbell ^d   Chowdary, Pratima ^e   Collins, Peter W ^f   Meijer, Karina ^g   Roosendaal, Goris ^a   Schutgens, Roger E G ^a   Mauser Bunschoten, Eveline P ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^d GLASGOW ROYAL INFIRMARY   (United Kingdom)

^e ROYAL FREE HOSPITAL   (United Kingdom)

^f UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cardiovascular disease; Haemophilia; Hypertension; QRISK; Risk profile

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE SEVERITY; ETHNICITY; HEMOPHILIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALGORITHMS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; GREAT BRITAIN; HEMOPHILIA A; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; OBESITY; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING; TIME FACTORS;

EID: 84872248761     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-05-0332     Document Type: Article

References (22)

1. Plug I, et al. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost 2006; 4: 510-516.
2. Darby SC, et al. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 2007; 110: 815-825.
3. Koumbarelis E, et al. Epidemiology of haemophilia in Greece: an overview. Thromb Haemost 1994; 72: 808-813.
4. Rosendaal FR, et al. Haemophilia protects against ischaemic heart disease: a study of risk factors. Br J Haematol 1990; 75: 525-530.
5. Siboni SM, et al. Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. J Thromb Haemost 2009; 7: 780-786.
6. Biere-Rafi S, et al. Cardiovascular risk assessment in haemophilia patients. Thromb Haemost 2011; 105: 274-278.
7. Lim MY, Pruthi RK. Cardiovascular disease risk factors: prevalence and management in adult hemophilia patients. Blood Coagul Fibrinolysis 2011; 22: 402-406.
8. Bilora F, et al. Does hemophilia protect against atherosclerosis? A case-control study. Clin Appl Thromb Hemost 2006; 12: 193-198.
9. Foley CJ, et al. Coronary atherosclerosis and cardiovascular mortality in hemophilia. J Thromb Haemost 2010; 8: 208-211.
10. Walsh M, et al. Health-related quality of life in a cohort of adult patients with mild hemophilia A. J Thromb Haemost 2008; 6: 755-761.
11. Hofstede FG, et al. Obesity: a new disaster for haemophilic patients? A nationwide survey. Haemophilia 2008; 14: 1035-1038.
12. Fransen van de Putte DE, et al. Non-fatal cardiovascular disease, malignancies and other co-morbidity in adult haemophilia patients. Thromb Res 2012; 130: 157-162.
13. Primatesta P, Poulter NR. Improvement in hypertension management in England: results from the Health Survey for England 2003. J Hypertens 2006; 24: 1187-1192.
14. Collins GS, Altman DG. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. Br Med J 2010; 340: c2442.
15. Hippisley-Cox J, et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. Br Med J 2007; 335: 136.
16. Hippisley-Cox J, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. Br Med J 2008; 336: 1475-1482.
17. Conroy RM, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003.
18. Sharathkumar AA, et al. Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US). Haemophilia 2011; 17: 597-604.
19. Wisniewska-Ligier M, et al. Lipid metabolism in children with chronic hepatitis C, A preliminary report. Hepatogastroenterology 2006; 53: 887-891.
20. Dai CY, et al. Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study. J Hepatol 2008; 49: 9-16.
21. Berger JS, et al. Screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol 2010; 55: 1169-1177.
22. Dent TH. Predicting the risk of coronary heart disease I. The use of conventional risk markers. Atherosclerosis 2010; 213: 345-351.